AGEN
USDAgenus Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$3.840
고가
$3.980
저가
$3.700
거래량
0.33M
기업 기본 정보
시가총액
126.8M
산업
생명공학
국가
United States
거래 통계
평균 거래량
0.46M
거래소
NCM
통화
USD
52주 범위
관련 뉴스
HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $23 Price Target
HC Wainwright & Co. analyst Emily Bodnar reiterates Agenus with a Buy and maintains $23 price target.
France Grants Reimbursed Compassionate Access (AAC) for Agenus' BOT/BAL in Refractory MSS Metastatic Colorectal Cancer
Agenus Inc. (NASDAQ:AGEN), a leader in immuno‑oncology, today announced its investigational combination botensilimab plus balstilimab (BOT/BAL) is now available to eligible patients with refractory microsatellite‑stable
Agenus Inc. (AGEN) Virtual Stakeholder Briefing Call (Transcript)
Agenus Inc. (AGEN) Virtual Stakeholder Briefing Call (Transcript)
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone
Federal budget cuts have put pressure on cancer research efforts in the United States, but private investment is helping to fill the gap, with...
HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $23 Price Target
HC Wainwright & Co. analyst Emily Bodnar reiterates Agenus with a Buy and maintains $23 price target.
Update: Agenus Aug 27 Stakeholder Webcast—Transformative IO Updates, BOT/BAL Data, BATTMAN Preview, Zydus Partnership Momentum, and MiNK Spotlight
Webcast details updated from the August 11th release Webcast on Wednesday, August 27, 2025 at 4:00 p.m. EST Agenus Inc. ("Agenus") (Nasdaq: AGEN), a leader in immuno-oncology, today announced an update to its
관련 주식
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기